(1)
Panalgo's IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use
BOSTON, Jan. 6, 2021 /PRNewswire/ -- Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data.
EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) accessible in-house (currently data from the UK, France, and Germany) to more quickly examine drug utilization, assess safety/efficacy, understand how treatments perform in real-world settings, and support public health efforts in the European Union (EU).